A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata.
Clinical trial NCT07205159 · RECRUITING
Trial details
- NCT number
- NCT07205159
- Sponsor
- Forte Biosciences, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-10-23
- Primary completion
- 2027-03-10
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.